CP-103 Subcutaneous single-use injection device and intravenous formulations in patients with HER2-positive early breast cancer

I Martin Nuñez; G Lopez-Vivanco; J Salvador; I Porras; C Ramirez

doi:10.1136/ejhpharm-2013-000436.101

Article info

Clinical Pharmacy

CP-103 Subcutaneous single-use injection device and intravenous formulations in patients with HER2-positive early breast cancer

Authors

I Martin Nuñez 1Roche Farma SA, Government Affairs, Madrid, Spain PubMed articles Google scholar articles
G Lopez-Vivanco 2Hospital de Cruces, Department of Medical Oncology, Barakaldo, Spain PubMed articles Google scholar articles
J Salvador 3Hospital Nuestra Señora de Valme, Department of Medical Oncology, Dos Hermanas, Spain PubMed articles Google scholar articles
I Porras 4Hospital Provincial Reina Sofia de Cordoba, Department of Medical Oncology, Cordoba, Spain PubMed articles Google scholar articles
C Ramirez 5Roche Farma SA, Medical Department, Madrid, Spain PubMed articles Google scholar articles

Citation

Martin Nuñez I, Lopez-Vivanco G, Salvador J, et al

CP-103 Subcutaneous single-use injection device and intravenous formulations in patients with HER2-positive early breast cancer

European Journal of Hospital Pharmacy 2014;21:A41-A42.

Publication history

First published February 24, 2014.

Online issue publication

September 27, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password